Loading…
Our company is deeply engaged in biotechnology and the health industry. Since the establishment of the Qinling Research Institute in 2010, we have gradually developed into a comprehensive enterprise integrating R&D, production, sales, contract manufacturing, and foreign trade. A stable core team has laid a solid foundation for the company's long-term development. In 2012, relying on the high-quality Chinese medicinal materials production resources in Ning County, Qingyang City, Gansu Province, the Ning County Hengruikang Factory was established and put into operation. It has built a modern production system and a professional quality inspection platform, achieving nearby raw material procurement and full-process quality control. The enterprise has always practiced social responsibility, creating a large number of jobs, increasing the income of surrounding farmers, contributing local taxes, and effectively promoting regional economic development. Since 2014, the company has focused on the field of food and medicinal dual-purpose extract and expanded OEM contract manufacturing services. In 2015, it established a sales branch in Xi'an, building a national marketing matrix and operating multiple platforms vertically. With the qualification of high-quality suppliers, it has enhanced its market competitiveness. In 2016, it set up a raw material direct supply base in southern Shaanxi, independently developed a digital supply chain system, achieving full-process traceability control, and significantly improving operational efficiency and customer repurchase rate. During its development, the company has steadily broken through and upgraded: In 2017, its sales exceeded 50 million yuan; In 2018, it entered Alibaba International Station to venture into foreign trade and simultaneously established a research and production cooperation with Shaanxi Normal University. Subsequently, it continuously optimized its raw material supply chain, extended its industrial chain, and successively established several subsidiaries, covering sectors such as cosmetic raw materials and deep processing of Ningxia wolfberries, thereby expanding its business territory. In 2022, its sales exceeded 120 million yuan, and it deepened research and development innovation in collaboration with Jiangnan University. In 2024, it completed the construction of a warehouse center at Xi'an Airport to upgrade its logistics system, and its foreign trade export volume exceeded 5 million US dollars. In 2025, the company invested 80 million yuan to start the construction of the Jingbian factory in northern Shaanxi, aiming to build a project for the deep processing and industrialization of traditional Chinese medicinal materials. This move is intended to further consolidate the strategic layout in the northwest region and drive local employment and industrial upgrading. After more than ten years of in-depth development, the company has formed a full industrial chain layout covering raw material planting, research and development, production, sales, foreign trade and OEM. Relying on its complete hardware facilities, strong technical strength, mature operation system and firm social responsibility, it is steadily moving towards the path of large-scale, international and diversified development.